As healthcare integration rises, patients face higher bills and limited choices, raising questions about compliance and care quality.

Anne Hug’s personal experience highlights the financial burden patients can face in a tightly integrated healthcare system. After a failed round of in vitro fertilization earlier this year, her fertility doctor suggested a relatively simple procedure to remove a polyp in her uterus. This could improve her chances of conceiving and was recognized by the American College of Obstetricians and Gynecologists as something that could be performed in an office setting with local anesthesia.
Following that advice, Hug was referred to another physician within the same large Ohio health system for the procedure. However, she faced an unexpected estimate of $18,000 due to the hospital's plan to perform the procedure under general anesthesia in an operating room. Concerned about the high costs, she sought out a different obstetrician willing to carry out the procedure in his office for approximately $3,000.
Just a day before the operation, Hug received a phone call notifying her that the procedure had to be performed in a freestanding surgery center owned by the same health system. Even though the professional guidelines suggested a simpler execution, Hug found herself in a more elaborate environment with unnecessary staffing. She recalls engaging casually with the OR team as her procedure, which only required local anesthesia, took place.
The final bill ended up being around $6,000. Hug is left questioning the legality of these practices that appear to direct patients towards more expensive options despite established recommendations for less costly alternatives.
The Rise of Vertical Integration
This scenario encapsulates a broader trend in the U.S. healthcare system, where vertical integration has become increasingly prevalent. Hospitals are acquiring doctors' practices, surgery centers, and imaging facilities at an alarming rate. Insurers are not only purchasing practices but are also merging with pharmacies, while private equity firms invest heavily in healthcare by buying out practices, optimizing operations, and then reselling them.
Despite claims that this integration is intended to enhance efficiency, studies indicate that it often leads to higher prices for patients without any corresponding improvements in care quality. According to Soroush Saghafian, an associate professor at Harvard University’s Belfer Center for Science and International Affairs, these integrations primarily focus on financial efficiency rather than actual patient care.
Recent trends show a significant shift in how healthcare is structured: currently, over 82% of physicians are employed by hospitals or corporate entities. For instance, in 2024, UnitedHealth Group noted it employed around 10,000 primary care physicians—apart from its large network of affiliated doctors. The regulatory framework governing these mergers is lagging, notably under the Hart-Scott-Rodino Act, which requires only sizable mergers to be reported, leaving many smaller integrations unnoticed.
The Regulatory Response
While the Federal Trade Commission (FTC) and the Justice Department monitor these mergers to promote competition and patient choice, they grapple with both limited resources and regulatory tools. Any action taken against these consolidations often feels sluggish, exacerbating the challenges facing consumers. Agencies currently rely on news reports to catch smaller transactions, which means many unreported consolidations fly under the radar.
From a policy perspective, horizontal mergers—those between similar types of healthcare providers—are more easily analyzed in terms of patient impact and cost. But vertical mergers introduce complexities. While the theory suggests that combining hospitals and insurers may create efficiencies, real-world outcomes show that such deals can facilitate cost increases and diminish consumer choice.
The promise of enhanced patient care or reduced costs is often overshadowed by evidence of decreased quality. For example, research evaluating hospital acquisitions of gastroenterology groups revealed that while efficiency metrics improved, patient care quality deteriorated, raising complication rates.
Patients Caught in the Crossfire
Patients are frequently pushed into higher-cost facilities and directed to specific pharmacies that might not offer the lowest prices or best access to prescribed medications. Such outcomes lead to a situation where patients feel they have no choice but to adhere to their insurer's offerings, often at greater financial cost. The lack of choice has financial repercussions that filter down to consumers who see their out-of-pocket costs rise dramatically due to unforeseen factors like deductibles and the management of prescription benefits.
For example, Ari H., a Florida resident, found himself facing elevated expenses after switching to a new insurance plan that restricted him to specific pharmacy networks, eliminating the financial assistance he previously received from his former plan provider. "It feels like double-dipping," he noted, encapsulating a frustration that many patients share in an increasingly interconnected healthcare market.
The sequence of vertical integrations has made it cumbersome for patients to access medications affordably, as seen with major insurers like Cigna and UnitedHealth, who own both specialty pharmacies and pharmacy benefit managers. The economic landscapes shaped by these conglomerates complicate the basics of patient care, leaving many at the mercy of corporate actions that prioritize profit over well-being.
Looking Ahead
As healthcare continues to evolve under the influence of vertical integration, the implications for patient care and medical costs remain significant. With influential stakeholders like the FTC advocating for regulatory reforms, the conversation about site-neutral payments—paying the same amount for procedures regardless of location—gains momentum. However, the complexities of existing structures mean that any foundational shifts toward patient-centric systems will take time and considerable advocacy.
Ultimately, while vertical integration proposes great efficiencies, it remains imperative to ensure that patient care remains at the forefront of these market strategies, lest healthcare become a system characterized solely by profit margins rather than patient outcomes.
KFF Health News is a national newsroom that produces in-depth journalism about health issues. Read more at KFF.This article first appeared on KFF Health News.
Discussion
Sign in to join the discussion.